New EU anti-counterfeiting rules: comprehensive but costly
This article was originally published in Scrip
New legislation on tackling the trade in falsified medicines has been given the green light by EU ministers, paving the way for novelties such as safety features on practically all prescription drug packs, a clampdown on internet sales, and closer supervision of manufacturing activities.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
The UK has used a special legislative process to temporarily authorize the use of the BNT-162b2 vaccine, with the first 800,000 shots expected to be delivered within days.